Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: EYDIS BIO, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-09-29 to 2026-09-29
Current total value of award: $499825
Description: PERFORM A STRUCTURE ACTIVITY RELATIONSHIP (SAR), MOLECULAR BINDING AND METABOLISM OF THE LEAD SCAFFOLD (HS-176) TO GUIDE THE DEVELOPMENT OF MORE POTENT AND DRUG LIKE ANALOGS, AND PRIORITIZATION OF LEAD ANALOGS THROUGH IN VITRO EFFICACY SCREENING AND